BPA Call 36E79721A0002-36C26223N0287
Award Date
2/24/23
Potential Completion Date
2/23/24
Potential Value
Not listed
Federal Agency
Veterans Integrated Service Network 22
Ultimate Awardee
Bayer AG
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Dublin, OH 43017, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award by the Department of Veterans Affairs (VA) Veterans Health Administration to Bayer Healthcare Pharmaceuticals Inc. for the delivery of the radiopharmaceutical XOFIGO. The contract has a potential value of $124,435.98 and is a Firm Fixed Price Delivery Order under Bayer's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. The contract does not have a small business set-aside designation. Bayer Healthcare Pharmaceuticals Inc. is a subsidiary of...
This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Bayer Healthcare Pharmaceuticals Inc. for the delivery of the radiopharmaceutical product XOFIGO. The contract, which has a potential value of $155,964.21, is a Delivery Order placed under Bayer's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract is for a Firm Fixed Price and has a completion date of September 30, 2018. Bayer Healthcare...
This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Bayer Healthcare Pharmaceuticals Inc., a subsidiary of the Bayer AG conglomerate. The contract, valued at $313,519.58, is for the delivery of the prostate cancer drug XOFIGO. The contract was awarded on a Firm Fixed Price basis under Bayer's Federal Supply Schedule 61 contract for Pharmaceuticals and Drugs. No small business set-aside was used. Bayer Healthcare Pharmaceuticals Inc....
This is a federal contract award to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company, for the delivery of XOFIGO, a specialized radiopharmaceutical product for the treatment of prostate cancer. The contract, valued at $90,214.74, was awarded by the Department of Veterans Affairs (VA) on October 23, 2019, with a completion date of May 31, 2020. The contract is a delivery order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB),...
This is a federal contract award to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit organization, for the delivery of XOFIGO, a radiopharmaceutical product used in the treatment of prostate cancer. The contract, with a ceiling value of $82,156.02, was awarded by the Department of Veterans Affairs (VA) on October 24, 2016, and has an ultimate completion date of September 30, 2017. The contract is a delivery order under the VA's Pharmaceuticals and Drugs Federal Supply...
Bayer Healthcare Pharmaceuticals Inc., a subsidiary of Bayer AG focused on pharmaceutical research and marketing, has been awarded a $177,199.13 delivery order for XOFIGO GLA by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22. The delivery order was issued under Bayer's multiple award schedule contract for pharmaceuticals and drugs, referred to as FSS-61-IB, with the work being performed in Dublin, OH. No set aside designation was...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a $92,491.80 delivery order to Bayer Healthcare Pharmaceuticals Inc. for 690 doses of the brand name prostate cancer drug Xofigo (radium Ra 223 dichloride). Xofigo is manufactured by Bayer AG's Pharmaceuticals division with distribution by Cardinal Health as the authorized vendor. The delivery order was issued against the Pharmaceuticals and Drugs Federal Supply Schedule contract...
The Department of Veterans Affairs (VA) awarded a delivery order contract to Bayer Healthcare Pharmaceuticals Inc. for the provision of the radiopharmaceutical drug XOFIGO (radium Ra-223) for the period of October 1, 2017 to September 30, 2018. The $359,276.04 firm fixed price contract was placed under Bayer's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. As a major supplier of pharmaceuticals and other medical products to federal agencies, Bayer has held...
This is a federal contract award from the Department of Veterans Affairs (VA) Veterans Health Administration to Bayer Healthcare Pharmaceuticals Inc. for the provision of the radioactive prostate cancer drug Xofigo. The $117,422.64 firm fixed-price purchase order is for emergency treatment studies for two cancer patients. Bayer Healthcare Pharmaceuticals Inc. is a subsidiary of Bayer AG that supplies pharmaceuticals and medical products to government customers. The company has multiple...
This federal contract award is for the delivery of the pharmaceutical product XOFIGO to the Department of Veterans Affairs (VA). The contract was awarded to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit organization, on November 23, 2016 with a ceiling value of $229,390.89. The contract is a Delivery Order under Bayer's GSA Schedule 61 contract for Pharmaceuticals and Drugs, which allows various federal agencies to place orders for a broad range of pharmaceutical products....